Updated:
Gardior
Gardior is a fund of funds management organisation founded in 1998 in Australia. It focuses on private investments in the biotech and life science sectors.
Gardior
Gardior is a fund of funds management organisation founded in 1998 in Australia. It focuses on private investments in the biotech and life science sectors.
General information
Firm type
Private Equity
Location
Region
Oceania
Country
Australia
City
Brisbane
Corporate office
Brisbane, Australia
Principals
David Williams
Director
Pauline Williams
Director
Andrew Coppin
Director
Sector focus
Frequently asked questions
Who runs investment decisions at Gardior?
David Williams, Pauline Williams and Andrew Coppin are listed as directors of Gardior, per ASIC corporate records. Investment decisions are made at the board level, with the firm operating as trustee and manager of the PCG Investment Trust. Specific investment committee members or advisory structures beyond the board are not publicly disclosed.
Does Gardior make direct investments or only fund commitments?
Gardior operates as a fund-of-funds manager, committing capital to third-party private equity and infrastructure funds. There is no public evidence that the firm executes direct co-investments or direct company deals. Its strategy centers on manager selection rather than direct asset ownership.
Which geographies does Gardior target?
Gardior's fund commitments are focused on Australia and the Asia-Pacific region. The firm has not disclosed specific fund relationships, but its Brisbane base and regulatory filings point to a predominantly Australian allocation with selective pan-Asian exposure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: